WARREN, N.J. (AP) — WARREN, N.J. (AP) — Aquestive Therapeutics Inc. (AQST) on Tuesday reported a loss of $2.7 million in its second quarter.

The Warren, New Jersey-based company said it had a loss of 3 cents per share.

The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 11 cents per share.

The specialty pharmaceutical company posted revenue of $20.1 million in the period, which also topped Street forecasts. Five analysts surveyed by Zacks expected $12.6 million.

Aquestive Therapeutics expects full-year revenue in the range of $57 million to $60 million.

In the final minutes of trading on Tuesday, the company's shares hit $3.40. A year ago, they were trading at $2.05.

_____

This story was generated by Automated Insights (https://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AQST at https://www.zacks.com/ap/AQST